Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lindemann

Showing results (1-10 of 206) with videos related to

Pageof 21
Sort By:
Infection and Immunity|June 1, 1989
Roles of interferon and cellular adhesion molecules in bacterial activation of human natural killer cellsR A Lindemann
Infection and Immunity|May 1, 1988
Bacterial activation of human natural killer cells: role of cell surface lipopolysaccharideR A Lindemann
Journal of Periodontal Research|November 1, 1991
The regulatory effects of monocytes on human natural killer cells activated by lipopolysaccharidesR A Lindemann
Cancer Treatment and Research|January 1, 1995
Interleukin-3 and its receptorA Lindemann, R Mertelsmann
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Vascular complications in patients treated with granulocyte colony-stimulating factor (G-CSF)A Lindemann, B Rumberger
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Cytokines in clinical cancer treatment trials: methodological aspectsU Brennscheidt, A Lindemann
Human Genetics|September 1, 1988
Maternal levels of pregnancy-specific beta 1-glycoprotein (SP-1) are elevated in pregnancies affected by Down's syndromeI Bartels, A Lindemann
Der Internist|February 7, 1998
[Gene therapy. A realistic approach to treating malignant diseases?]A Lindemann, R Mertelsmann
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Scheduling of ultra low dose interleukin-2 in immunotherapyA Lindemann, R Mertelsmann
Deutsche Medizinische Wochenschrift (1946)|February 12, 1998
[Molecular medicine--from genes to therapy]A Lindemann, R Mertelsmann
Pageof 21

Showing results (1-10 of 206) with videos related to

Sort By:
Pageof 21
Infection and Immunity|June 1, 1989
Roles of interferon and cellular adhesion molecules in bacterial activation of human natural killer cellsR A Lindemann
Infection and Immunity|May 1, 1988
Bacterial activation of human natural killer cells: role of cell surface lipopolysaccharideR A Lindemann
Journal of Periodontal Research|November 1, 1991
The regulatory effects of monocytes on human natural killer cells activated by lipopolysaccharidesR A Lindemann
Cancer Treatment and Research|January 1, 1995
Interleukin-3 and its receptorA Lindemann, R Mertelsmann
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Vascular complications in patients treated with granulocyte colony-stimulating factor (G-CSF)A Lindemann, B Rumberger
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Cytokines in clinical cancer treatment trials: methodological aspectsU Brennscheidt, A Lindemann
Human Genetics|September 1, 1988
Maternal levels of pregnancy-specific beta 1-glycoprotein (SP-1) are elevated in pregnancies affected by Down's syndromeI Bartels, A Lindemann
Der Internist|February 7, 1998
[Gene therapy. A realistic approach to treating malignant diseases?]A Lindemann, R Mertelsmann
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Scheduling of ultra low dose interleukin-2 in immunotherapyA Lindemann, R Mertelsmann
Deutsche Medizinische Wochenschrift (1946)|February 12, 1998
[Molecular medicine--from genes to therapy]A Lindemann, R Mertelsmann
Pageof 21